The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Autologous genetically engineered NY-ESO-1c259T in HLA-A*02:01, HLA*02:05 and HLA*02:06 positive patients with NY-ESO-1 expressing tumors.
 
Crystal Mackall
Research Funding - Neomune
Patents, Royalties, Other Intellectual Property - I am a co-inventor on patents pending for chimeric antigen receptors targeting B7-H3, ALK and CD276.
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono
 
Stephan A. Grupp
Consulting or Advisory Role - Janssen; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Novartis
 
Kunle Odunsi
Research Funding - ITeos Therapeutics (Inst)
 
Mihaela C. Cristea
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Trovagene
 
Gerald P. Linette
No Relationships to Disclose
 
Harriet M. Kluger
Honoraria - Merck
Consulting or Advisory Role - Prometheus
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Gabor Kari
Employment - Adaptimmune
 
Lini Pandite
Employment - Adaptimmune; GlaxoSmithKline
 
Tom Holdich
Employment - Adaptimmune
 
Elliot Norry
Employment - Adaptimmune; GlaxoSmithKline
 
Gwendolyn Binder-Scholl
Employment - Adaptimmune
 
Rafael G. Amado
Employment - Adaptimmune; GlaxoSmithKline